A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin
Carolina M. Casselini(Eastern Virginia Medical School), Nigel A. Calcutt(University of California San Diego)
Cited by 14
Related Papers
Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy
|Journal of Clinical Investigation|2017|90